DrugDashboards

Ranolazine

Ranolazine · RANOLAZINE 1000 mg/1 · Tablet, Film Coated, Extended Release · Oral · A2A Integrated Pharmaceuticals

NDC 73141-0022-02 · 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.7844per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$0.4375per unitA2A Alliance Pharmaceuticals, LLC · Jun 25, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for ranolazine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA213517
TE code
AB
Approval date
Apr 27, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ranolazine (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Aphena Pharma Solutions - Tennessee, LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedRANOLAZINE 1000 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPRANOLAZINE 500 mg/1Jul 15, 2026Sep 3, 2026
A2A Integrated PharmaceuticalsRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
A2A Integrated PharmaceuticalsRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
AvKARERANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
AvKARERANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
AvPAKRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
AvPAKRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.RANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.RANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USARANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USARANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
i3 Pharmaceuticals, LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
i3 Pharmaceuticals, LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Radha Pharmaceuticals, IncRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Radha Pharmaceuticals, IncRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
SunGen Pharma LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
SunGen Pharma LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharma, Inc.RANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharma, Inc.RANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.RANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.RANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Zameer Pharmaceuticals LLCRANOLAZINE 500 mg/1Jul 15, 2026Sep 2, 2026
Zameer Pharmaceuticals LLCRANOLAZINE 1000 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ranolazine — NDC 73141-0022-02," retrieved September 3, 2026, https://drugdashboards.com/drug/73141002202.

Free to cite with attribution — see how the data is put together.